- Home
- FTI vs BAX Comparison
FTI vs BAX Comparison
Compare FTI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- BAX
- Stock Information
- Founded
- FTI 1884
- BAX 1931
- Country
- FTI United States
- BAX United States
- Employees
- FTI N/A
- BAX N/A
- Industry
- FTI Metal Fabrications
- BAX Medical/Dental Instruments
- Sector
- FTI Industrials
- BAX Health Care
- Exchange
- FTI Nasdaq
- BAX Nasdaq
- Market Cap
- FTI 16.6B
- BAX 11.3B
- IPO Year
- FTI N/A
- BAX N/A
- Fundamental
- Price
- FTI $42.51
- BAX $17.94
- Analyst Decision
- FTI Strong Buy
- BAX Hold
- Analyst Count
- FTI 11
- BAX 10
- Target Price
- FTI $45.60
- BAX $27.00
- AVG Volume (30 Days)
- FTI 4.4M
- BAX 7.6M
- Earning Date
- FTI 10-23-2025
- BAX 10-30-2025
- Dividend Yield
- FTI 0.47%
- BAX 3.79%
- EPS Growth
- FTI 59.09
- BAX N/A
- EPS
- FTI 2.28
- BAX N/A
- Revenue
- FTI $9,803,000,000.00
- BAX $11,023,000,000.00
- Revenue This Year
- FTI $10.39
- BAX $5.72
- Revenue Next Year
- FTI $7.41
- BAX $2.52
- P/E Ratio
- FTI $18.58
- BAX N/A
- Revenue Growth
- FTI 11.44
- BAX 3.90
- 52 Week Low
- FTI $22.12
- BAX $17.47
- 52 Week High
- FTI $43.09
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- FTI 66.85
- BAX 19.30
- Support Level
- FTI $41.06
- BAX $17.47
- Resistance Level
- FTI $43.09
- BAX $18.16
- Average True Range (ATR)
- FTI 1.34
- BAX 0.56
- MACD
- FTI 0.34
- BAX -0.45
- Stochastic Oscillator
- FTI 91.71
- BAX 6.73
About FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.